Kerstin Nagel-Wolfrum

Title: Kerstin Nagel-Wolfrum: Innovator in Ophthalmic Research

Introduction

Kerstin Nagel-Wolfrum is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of ophthalmic research, particularly in developing therapeutic agents for Usher syndrome. Her innovative work has the potential to transform the understanding and treatment of this genetic disorder.

Latest Patents

Kerstin holds a patent for a "Large animal model for developing therapeutic agents to treat impaired ophthalmic function in Usher syndrome." This patent describes new animal models that facilitate the study of Usher syndrome and the development of novel therapies. The technology is implemented in pigs and other large animals, which possess ophthalmic architecture and function that closely resemble those of the human eye. The animals are genetically modified to include a human gene associated with Usher syndrome, allowing researchers to study the condition more effectively. These models can be cloned or bred to be homozygous at the targeted locus, leading to the manifestation of symptoms similar to those seen in human patients. This advancement enables the development and testing of pharmacological agents, including gene therapies that are sequence-dependent.

Career Highlights

Throughout her career, Kerstin has worked with notable organizations, including the Usher 2020 Foundation and the Georg-Speyer-Haus Chemotherapeutisches Forschungsinstitut. Her work has been instrumental in advancing the understanding of Usher syndrome and developing potential treatments.

Collaborations

Kerstin has collaborated with esteemed colleagues such as Uwe Wolfrum and Nikolai Klymiuk. Their combined expertise has contributed to the success of her research and the development of innovative solutions for ophthalmic disorders.

Conclusion

Kerstin Nagel-Wolfrum's contributions to ophthalmic research and her innovative patent for a large animal model represent significant advancements in the field. Her work not only enhances the understanding of Usher syndrome but also paves the way for potential therapeutic interventions.